Michael S. Perry, Chief Executive Officer at Avita Therapeutics, Inc. (RCEL), sold 34,256 shares at $26.02 ($895K) on 2020-09-11, disclosed to the SEC on 2020-09-11.
Open-market sale of $895k RCEL by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.26 | 7,128 | $187K | 20.9% |
| 2 | $26.26 | 7,128 | $187K | 20.9% |
| 3 | $26.02 | 20,000 | $520K | 58.2% |
| Total | $26.12 avg | 34,256 | $895K | 100% |
| Filing → |
| RCEL | SELL | 2022-11-22 | $1.1M | — | Filing → |
| RCEL | SELL | 2022-02-25 | $189K | — | Filing → |
| ARWR | SELL | 2022-01-04 | $460K | — | Filing → |